Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism in individuals with prediabetes: A randomized controlled trial
Andrew L Siebel, Khiang Trinh Si, Melissa F Formosa, Piyushkumar A Mundra, Alaina K Natoli, Medini Reddy-Luthmoodo, Kevin Huynh, Anmar A Khan, Andrew L Carey, Gerrit van Hall, Claudio Cobelli, Chiara Dalla-Man, Jim D Otvos, Kerry-Anne Rye, Jan Johansson, Allan Gordon, Norman CW Wong, Dmitri Sviridov, Philip Barter, Stephen J Duffy Show all
Metabolism | W B SAUNDERS CO-ELSEVIER INC | Published : 2016
Awarded by National Health & Medical Research Council (NHMRC) of Australia
This study was supported by Resverlogix Corp., the National Health & Medical Research Council (NHMRC) of Australia (APP1065462) to BAK, SJD and ALS, and in part by the Victorian Government's Operational Infrastructure Support (OIS) Program. BAK, DS and PJM are all supported by NHMRC Research Fellowships.